Chronic Lymphocytic Leukemia Research Consortuim
CRC Research CRC Sites Clinical Trials For Patients Biorepository Publications & News How to Donate

Thomas Kipps, MD, PhD


The CLL Research Consortium (CRC) is a multi-institutional program project, funded, in part, by the National Institute of Health. The consortium has brought together institutions that, under normal circumstances, would not engage one another as they currently can under the auspices of CRC. The Consortium includes the following clinical sites: Moores UCSD Cancer Center, M.D. Anderson Cancer Center, Ohio State University Cancer Center, North Shore-Long Island Jewish Medical System, Dana-Farber Cancer Institute, Mayo Clinic, and several sites that perform laboratory work alone, including The Burnham Institute and Barts and the London Cancer Center. These institutions see a diverse patient population and all possess high quality basic science laboratories. Bringing these sites together in the context of the CRC has resulted in a program that is much more than the sum of its parts.


CRC Sites

Currently there are seven clinical sites in the CRC. These institutions see a diverse patient population and all possess high quality basic science laboratories.

Find the location closest to you.

Clinical Trials

The CRC is developing new and innovative curative strategies for CLL.

Read about our current trials.

For Patients

Answers to the questions, what is Chronic Lymphocytic Leukemia (CLL) & what causes CLL? A glossary of terms and the latest publications & articles.

Visit our patients section.

Biorepository

The Tissue Core of this consortium provides the necessary infrastructure for all the projects to achieve their potential and expedite their findings.

Read more about the Tissue Core.


contact us home